Not all anti-T lymphocyte globulin preparations are suitable for use in aplastic anemia: significantly inferior results with jurkat cell-reactive anti-T lymphocyte globulin in clinical practice

Background: Immunosuppressive therapy (IST) with anti-T lymphocyte globulin (ATG) plus cyclosporine (CSA) is standard therapy in patients with non-severe aplastic anemia (AA) in need of treatment and severe aplastic anemia (SAA) who do not have an available HLA-matched donor. The aim of this study w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Clin Exp Med
Autors principals: Eylem, Eliacik, Yahya, Buyukasik, Ozlen, Bektas, Umit, Malkan, Gursel, Gunes, Ayse, Isik, Haluk, Demiroglu, Salih, Aksu, Hakan, Goker, Nilgun, Sayinalp, Ibrahim, Haznedaroğlu, Osman, Ozcebe
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4659041/
https://ncbi.nlm.nih.gov/pubmed/26629153
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars